Satoki Doi
Japan Tobacco (Japan)(JP)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, NF-κB Signaling Pathways, Biochemical and Molecular Research, Biochemical Acid Research Studies, Hepatitis C virus research
Most-Cited Works
- → Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137)(2007)343 cited
- → Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors(2006)111 cited
- → SAR Exploration Guided by LE and Fsp 3 : Discovery of a Selective and Orally Efficacious RORγ Inhibitor(2015)58 cited
- → Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (Delgocitinib) as a New Dermatological Agent to Treat Inflammatory Skin Disorders(2020)52 cited
- → Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold(2019)31 cited
- → Ternary complex of human RORγ ligand‐binding domain, inverse agonist and SMRT peptide shows a unique mechanism of corepressor recruitment(2017)27 cited
- → Ternary crystal structure of human RORγ ligand-binding-domain, an inhibitor and corepressor peptide provides a new insight into corepressor interaction(2018)18 cited
- → Discovery of a novel azetidine scaffold for colony stimulating factor-1 receptor (CSF-1R) Type II inhibitors by the use of docking models(2018)15 cited
- → Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases(2021)14 cited
- → The discovery of 3,3-dimethyl-1,2,3,4-tetrahydroquinoxaline-1-carboxamides as AMPD2 inhibitors with a novel mechanism of action(2022)9 cited